Received Oct 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
left arm is experiencing significant soreness; fatigue; Light headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm is experiencing significant soreness), FATIGUE (fatigue) and HEADACHE (Light headache) in a patient of an unknown age and gender who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. Co-suspect product included non-company product Influenza vaccine (Flu) for an unknown indication. No Medical History information was reported. On 09-Oct-2025 at 5:00 AM, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (unknown route) 1 dosage form. On 09-Oct-2025 at 5:00 PM, the patient received dose of Influenza vaccine (Flu) (unknown route) 1 dosage form. In October 2025, the patient experienced PAIN IN EXTREMITY (left arm is experiencing significant soreness), FATIGUE (fatigue) and HEADACHE (Light headache). At the time of the report, PAIN IN EXTREMITY (left arm is experiencing significant soreness), FATIGUE (fatigue) and HEADACHE (Light headache) outcome was unknown. No concomitant medication was reported. Patent received Spikevax dose yesterday at 5 pm. Patient took it alongside the flu vaccine. patient left arm was experiencing significant soreness. Patient was also experiencing fatigue and a light headache. No treatment information was reported.